Lupus & antiphospholipid syndrome

Skin and beyond: Demographics, clinical features and systemic involvement of cutaneous lupus erythematosus in Pakistani population

LupusPublished Cross-sectional study

Authors' conclusion

The clinical characteristics of cutaneous lupus is similar to other studies, but the renal involvement is higher with cutaneous involvement in this study, while Serositis is less prevalent. Localized discoid lupus did not show extra cutaneous involvement, but showed significant impact on daily life.

Study context

Population
Patients with cutaneous lupus erythematosus (CLE) presenting with cutaneous symptoms, Pakistan
Participants
135 patients
Outcome
Clinical features and systemic involvement of CLE

Main finding

As reported in the abstract

Female
73.3%
Male
26.7%
Mean age (years)
28.1
Duration of CLE (months)
8.4
Rural area
56.3%
Isolated chronic CLE (CCLE)
35.5%
CCLE with overlap acute CLE (ACLE)
30.3%
Isolated ACLE
33.3%
Subacute CLE (patients)
2
Limited discoid rash
33.3%
Generalized discoid rash
17.7%
Malar rash
46.6%
Oral and nasal ulcers
51.1 %
Non-scarring alopecia
53.3%
Scarring alopecia
35.5%
RP
34%
Periungual telangiectasia
23.7%
Vasculitis
14.8%
Joint involvement, 49 patients
36.3%
Renal involvement, 48 patients
35.6%
Haematological involvement, 42 patients
31.1%
Serositis, 23 patients
17%
Neurological involvement, 14 patients
10.4%
ANA positive, 61 patients
45.1%
Anti-dsDNA positive, 42 patients (40 women)
31.1%

Observational data: associations, not effects.

Further findings

Impact on daily life (DLQI)

Mean DLQI
11.01 ± 8.2
No or slight effect on lives (patients)
45
Moderate effect
22.9%
Large effect
27.4%
Very large effect
16.3%

Original publication

Skin and beyond: Demographics, clinical features and systemic involvement of cutaneous lupus erythematosus in Pakistani population. Lupus. Published 28 March 2025. doi:10.1177/09612033251330115

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.